Effects of nicotine administration following 12 h of tobacco deprivation: assessment on computerized performance tasks - PubMed (original) (raw)
Clinical Trial
doi: 10.1007/BF00443406.
Affiliations
- PMID: 2496420
- DOI: 10.1007/BF00443406
Clinical Trial
Effects of nicotine administration following 12 h of tobacco deprivation: assessment on computerized performance tasks
F R Snyder et al. Psychopharmacology (Berl). 1989.
Abstract
The purpose of this study was to assess the effects of acute nicotine administration, following a 12-h cigarette deprivation period, using a computerized performance assessment battery (PAB). The PAB was comprised of five tasks which were selected to reflect a variety of complex acquired behaviors, sometimes referred to as "cognitive performance". Subjects were six healthy, male, cigarette smokers who practiced on the approximately 15 min PAB until their performance was stable across trials. In the training and baseline phase, subjects were tested following 5-30 min deprivation of cigarettes. Subjects were then tested following 12 h cigarette deprivation; 20 min before these sessions, subjects were given one piece of gum to chew. The gum contained 0, 2, or 4 mg nicotine, and it was chewed for 10 min at a rate of one chew every 2 s. There were two main findings: (1) when placebo (0 mg) gum was given, the time taken to complete the PAB tasks was significantly elevated above values obtained in the baseline condition; (2) compared to placebo, nicotine administration produced a dose-related decrease in the time taken to complete the tasks such that with either 2 or 4 mg, performance time was similar to that which occurred in the baseline cigarette smoking condition. Performance accuracy was not reliably affected by the experimental manipulations. These data indicate that the performance decrements observed in the placebo condition were specific to deprivation of nicotine following 12 h tobacco abstinence and are treatable using nicotine gum as a replacement formulation.
Similar articles
- Human aggressive responding during acute tobacco abstinence: effects of nicotine and placebo gum.
Cherek DR, Bennett RH, Grabowski J. Cherek DR, et al. Psychopharmacology (Berl). 1991;104(3):317-22. doi: 10.1007/BF02246030. Psychopharmacology (Berl). 1991. PMID: 1924639 - The tobacco withdrawal syndrome: performance decrements assessed on a computerized test battery.
Snyder FR, Davis FC, Henningfield JE. Snyder FR, et al. Drug Alcohol Depend. 1989 Jun;23(3):259-66. doi: 10.1016/0376-8716(89)90090-2. Drug Alcohol Depend. 1989. PMID: 2752917 - Effect of cigarettes on memory search and subjective ratings.
West R, Hack S. West R, et al. Pharmacol Biochem Behav. 1991 Feb;38(2):281-6. doi: 10.1016/0091-3057(91)90279-b. Pharmacol Biochem Behav. 1991. PMID: 2057498 - Improvements in performance without nicotine withdrawal.
Warburton DM, Arnall C. Warburton DM, et al. Psychopharmacology (Berl). 1994 Aug;115(4):539-42. doi: 10.1007/BF02245578. Psychopharmacology (Berl). 1994. PMID: 7871099 Clinical Trial. - Effects of the nicotine patch on performance during the first week of smoking cessation.
Cook MR, Gerkovich MM, Graham C, Hoffman SJ, Peterson RC. Cook MR, et al. Nicotine Tob Res. 2003 Apr;5(2):169-80. doi: 10.1080/1462220031000074873. Nicotine Tob Res. 2003. PMID: 12745489 Review.
Cited by
- Negative affective states and cognitive impairments in nicotine dependence.
Hall FS, Der-Avakian A, Gould TJ, Markou A, Shoaib M, Young JW. Hall FS, et al. Neurosci Biobehav Rev. 2015 Nov;58:168-85. doi: 10.1016/j.neubiorev.2015.06.004. Epub 2015 Jun 6. Neurosci Biobehav Rev. 2015. PMID: 26054790 Free PMC article. Review. - Double dissociation of working memory and attentional processes in smokers and non-smokers with and without nicotine.
Grundey J, Amu R, Ambrus GG, Batsikadze G, Paulus W, Nitsche MA. Grundey J, et al. Psychopharmacology (Berl). 2015 Jul;232(14):2491-501. doi: 10.1007/s00213-015-3880-7. Epub 2015 Feb 27. Psychopharmacology (Berl). 2015. PMID: 25721074 - Involvement of neuronal β2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapies.
Simmons SJ, Gould TJ. Simmons SJ, et al. J Clin Pharm Ther. 2014 Oct;39(5):457-67. doi: 10.1111/jcpt.12171. Epub 2014 May 14. J Clin Pharm Ther. 2014. PMID: 24828779 Free PMC article. Review. - COMT Val158Met modulates subjective responses to intravenous nicotine and cognitive performance in abstinent smokers.
Herman AI, Jatlow PI, Gelernter J, Listman JB, Sofuoglu M. Herman AI, et al. Pharmacogenomics J. 2013 Dec;13(6):490-7. doi: 10.1038/tpj.2013.1. Epub 2013 Mar 5. Pharmacogenomics J. 2013. PMID: 23459442 Free PMC article. - Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report.
Sofuoglu M, Herman AI, Li Y, Waters AJ. Sofuoglu M, et al. Psychopharmacology (Berl). 2012 Dec;224(3):413-20. doi: 10.1007/s00213-012-2763-4. Epub 2012 Jun 15. Psychopharmacology (Berl). 2012. PMID: 22700039 Free PMC article. Clinical Trial.
References
- J Psychosom Res. 1984;28(5):379-86 - PubMed
- Psychopharmacologia. 1975;41(1):1-5 - PubMed
- Percept Mot Skills. 1976 Apr;42(2):413-4 - PubMed
- Am J Psychiatry. 1978 Feb;135(2):220-2 - PubMed
- Psychol Rep. 1973 Jun;32(3):963-6 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources